Bringing the fundamentals into focus…
Back to USANA Health Sciences, Inc.
How USANA Health Sciences, Inc. stacks up
USNA · against 229 other Consumer Defensive companies of similar size
Valuation
84/ 100
Near the top of its peers.
Ranked #53 of 230 · scores higher than 77% of peers
Bars: peers in each 10-point band of the valuation score25 peers with a valuation score of 80–89, including USNA · Click a bar to see the companies
Why valuation scores 84?
Weighted metrics compared with all Consumer Defensive companies.Mainly thanks to its EBITDA yield, which is stronger than most Consumer Defensive peers.
- Negative (a loss or cash outflow), so it counts as zero whatever the share price. Earnings yield: -8.1% vs peer median 4.5%
- Free cash flow yield is close to the peer norm. Free cash flow yield: 5.8% vs peer median 6.2%
- more operating profit (EBITDA) for the company's total value: stronger than 98% of peers. EBITDA yield: 49.0% vs peer median 8.7%
Metric by metric
Position: dot = USNA, ranked from the worst peer (left) to the best (right); tick = middle, shaded = middle half of peers.| Metric | USNA | Peer median | Better than | Position among peers | Weight |
|---|---|---|---|---|---|
| Earnings yieldHigher is better · 217 reported | -7.9% | 4.7% | 11% | 30% | |
| EBITDA yieldHigher is better · 236 reported | 49.0% | 9.7% | 97% | 50% | |
| Free cash flow yieldHigher is better · 85 reported | 5.8% | 6.1% | 45% | 20% | |
| Book yieldHigher is better · 222 reported | 191.7% | 76.3% | 88% | Context only |
Ranking by valuation score
Top 5 and the companies ranked around USNAScores are sector-relative percentiles from the latest snapshot, always calculated against the whole sector: narrowing the comparison group changes who you compare with, not the scores. Missing metrics are left out and the remaining weights rescaled. How we score